Characterisation of Quality of Life-Linked Patient-Reported Outcomes Through a Digital & Continuous Remote Monitoring Ecosystem in Sickle Cell Disease

by alfie | Dec 15, 2023 | study and resources

SICKLE CELL DISEASE Characterisation of Quality of Life-Linked Patient-Reported Outcomes Through a Digital & Continuous Remote Monitoring Ecosystem in Sickle Cell Disease European Haematology Association (2023) Areas of interest /Longitudinal digital outcomes...

Real-World Outcomes and Digitally Monitored Quality of Life in Crizanlizumab-Treated Patients With Sickle Cell Disease

by alfie | Dec 15, 2023 | study and resources

SICKLE CELL DISEASE Real-World Outcomes and Digitally Monitored Quality of Life in Crizanlizumab-Treated Patients With Sickle Cell Disease European Haematology Association (2023) Areas of interest /Outcomes research & novel therapeutic impacts Biomarkers...

Real-World Outcomes and Digitally Monitored Quality of Life in Voxelotor-Treated Patients with Sickle Cell Disease

by alfie | Dec 15, 2023 | study and resources

SICKLE CELL DISEASE Real-World Outcomes and Digitally Monitored Quality of Life in Voxelotor-Treated Patients with Sickle Cell Disease Collaboration with Pfizer Ltd., American Society of Haematology Exposition (2023) Areas of interest /Outcomes research & novel...

Understanding the Experiences of Patients with Sickle Cell Disease and Their Caregivers By Social Media Listening in the UK

by alfie | Dec 15, 2023 | study and resources

SICKLE CELL DISEASE Understanding the Experiences of Patients with Sickle Cell Disease and Their Caregivers By Social Media Listening in the UK Collaboration with Pfizer Ltd., American Society of Haematology Exposition (2023) Areas of interest /Real-world experiences...

Disparate Prediction of Outcomes in A Uniformly Treated Cohort of Patients with AL Amyloidosis Stratified by Mayo 2012 & European Cardiac Staging Systems

by alfie | Dec 14, 2023 | study and resources

AMYLOIDOSIS Disparate Prediction of Outcomes in A Uniformly Treated Cohort of Patients with AL Amyloidosis Stratified by Mayo 2012 & European Cardiac Staging Systems Royal Free London NHS Foundation Trust (2023) Areas of interest /Prognostic markers & overall...
« Older Entries
Next Entries »